Eiger BioPharmaceuticals, Inc. Annual Interest Expense in USD from 2012 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Eiger BioPharmaceuticals, Inc. quarterly/annual Interest Expense history and growth rate from 2012 to 2023.
  • Eiger BioPharmaceuticals, Inc. Interest Expense for the quarter ending December 31, 2023 was $1.43M, a 16.9% increase year-over-year.
  • Eiger BioPharmaceuticals, Inc. Interest Expense for the twelve months ending December 31, 2023 was $5.47M, a 32.3% increase year-over-year.
  • Eiger BioPharmaceuticals, Inc. annual Interest Expense for 2023 was $5.47M, a 32.3% increase from 2022.
  • Eiger BioPharmaceuticals, Inc. annual Interest Expense for 2022 was $4.13M, a 16.1% increase from 2021.
  • Eiger BioPharmaceuticals, Inc. annual Interest Expense for 2021 was $3.56M, a 0.97% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $5.47M +$1.33M +32.3% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-08
2022 $4.13M +$573K +16.1% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-08
2021 $3.56M -$35K -0.97% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-17
2020 $3.59M +$188K +5.52% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-17
2019 $3.41M +$1.08M +46.2% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-10
2018 $2.33M +$805K +52.8% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-09
2017 $1.52M +$834K +121% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-13
2016 $690K +$340K +97.1% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-14
2015 $350K -$391K -52.8% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-09
2014 $741K +$682K +1156% Jan 1, 2014 Dec 31, 2014 10-K 2016-03-30
2013 $59K -$49K -45.4% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-30
2012 $108K Jan 1, 2012 Dec 31, 2012 10-K 2015-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.